TSC participated in the 22nd National
Innovation Award's "Enterprise Innovation Award - Agricultural and Food
Biotechnology Category" with its "Next-generation Porcine Epidemic
Diarrhea (PED) vaccine enhancing lactogenic immunity". After a three-stage
review by the judging panel, it successfully stood out for its technological
breakthrough, application benefits, and industrial value, winning the annual
National Innovation Award. The award ceremony was held in Grand Hilai Taipei,
and was personally presented by Prime Minister Jung-Tai Cho. TSC Chairman
Ming-Chang Wu led the research team of the project, including Taiwan Sugar
Research Institute (TSRI) Director, I-Jen Huang, Section Leader, Ji-Ming Yang,
and Dr. Dai-Ji Li, to attend the ceremony, demonstrating TSC's deep commitment
to developing independent animal vaccine technologies.
The National Innovation Award is a
benchmark competition in the domestic medical and biotechnology fields. TSRI
won the award for its independently developed PED vaccine with lactation
immunity, demonstrating the innovative value of this vaccine technology in both
scientific merit and practical application. It also reflects the achievements
of TSC in recent years in actively promoting sustainable livestock,
biotechnology R&D, and industrial upgrading. This national-level award is
expected to strengthen industry chain connections, increase technological
visibility, and promote commercialization.
TSC Chairman Ming-Chang Wu emphasized
that "promoting biotechnology autonomy and protecting the local livestock
industry are long-term goals of Taiwan Sugar Corporation". He added that
TSC will continue to deepen its vaccine platform and application research to
help the industry reduce disease risks, improve overall survival rates, and
increase production efficiency. Director of TSRI, Dr. I-Jen Huang, stated that
this award not only represents the innovative breakthroughs of the Taiwan Sugar
Research Institute in animal vaccine technology but also symbolizes a
significant milestone for TSC in biotechnology investment, industry-academia
collaboration, and sustainable livestock strategies.
TSC stated that it hopes to leverage
this National Innovation Award recognition to accelerate the commercialization
of vaccines and align them with international standards. It will also continue
to build a more comprehensive animal vaccine technology framework to provide
safer, standardized, and sustainable disease prevention solutions for the pig
farming industry in Taiwan and globally.
